Molecular Biosystems: The San Diego-based biomedical company...

Molecular Biosystems: The San Diego-based biomedical company reported a profit of $941,497 on revenue of $4.7 million, contrasted with a profit of $155,431 on revenue of $1.6 million for the same three months last year. Molecular Biosystems is developing a contrast agent used in cardiac ultrasound imaging tests.